+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Some comparative studies using 99mTc and 131I in thyroid scanning

Some comparative studies using 99mTc and 131I in thyroid scanning

Nuklearmedizin. Nuclear Medicine 15(6): 268-272

By comparing thyroid scans made with 99mTc and 131I in 40 euthyroid goiter patients large discrepancies were found in 20% of all cases. For example, "warm" nodules on 99mTc scans were found to be "cold" on 131I scans, or a "cold" nodule on a 99mTc scan was observed as a "warm" one on a 131I scan. The above discrepancies seem to result from the differences in the metabolism of the two radioisotopes in the thyroid and those in the time which elapsed between the administration of the radioisotope and the execution of the scan. Generally speaking 99mTc thyroid scintigraphy should not be recommended as a routine technique in adults, its usefulness being limited to the cases in which 131I scans were found to be illegible. "Cold" nodules on 99mTc scans should also be reexamined after T3 stimulation.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 041395273

Download citation: RISBibTeXText

PMID: 1012920

Related references

Thyroid scanning: a comparative study using 131I and 99mTc. Revista Medica de Chile 105(9): 619-621, 1977

A comparative study of 99mTc and 131I in thyroid scanning. European Journal of Nuclear Medicine 7(10): 444-446, 1982

Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA. Bratislavske Lekarske Listy 93(5): 258-265, 1992

Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I). Kaku Igaku. Japanese Journal of Nuclear Medicine 13(6): 775-779, 1976

Comparative accumulation of 99mTc and 131I in thyroid nodules: case report. Journal of Nuclear Medicine 18(4): 346-347, 1977

Comparative evaluation of renoscintigraphic properties and plasma clearance of 99MTc-DADS (99mTc-N,N'-bis/mercaptoacetamido ethylenediamine), 99mTc-DTPA and 131I-o-hippuran. Nuklearmedizin. Nuclear Medicine 22(3): 136-139, 1983

Should all patients with differentiated thyroid carcinoma undergo 131I SPECT-CT scanning rather than 131I whole-body scanning?. Nuclear Medicine Communications 36(6): 549-552, 2015

Comparison of 99mTc and 131I scans in thyroid function studies. South African Medical Journal 56(21): 839-840, 1979

Discordant imaging of a thyroid nodule with 131I and 99mTc: concordance of 131I and fluorescent scans. Radiology 128(3): 705-706, 1978

Comparative evaluation of 99mTc-pertechnetate, 99mTc-diphosphonate, 99mTc-Solcocitran, 99mTc-iron-ascorbic acid and 67Ga-citrate as brain scanning agents. Nuklearmedizin. Nuclear Medicine 21(6): 265-273, 1982

Clinical value of 99mTc-MIBI imaging, 131I whole body scan and HTG determination for the follow-up of patients with differentiated thyroid carcinoma after 131I therapy. Hua Xi Yi Ke Da Xue Xue Bao 30(4): 437-439, 1999

Tissue distribution studies in rats with two 131I-labeled adrenal scanning agents. Comparison between 131I-6-iodomethyl-19-norsitost-5(10)-en-3 beta-ol (NST-6-131I) and 19-iodositost-5-en-3 beta-ol (ST-19-131I). International Journal of Nuclear Medicine and Biology 6(3): 163-166, 1979

Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. Journal of Nuclear Medicine 29(1): 33-38, 1988

Comparative animal experiments on the distribution of 99mTc-mercaptopurines, 131I-bromosulphthalein and 99mTc-pertechnetate in the organism of the rat. Die Pharmazie 33(9): 603-604, 1978

Thyroid stunning after diagnostic whole body scanning with 185 MBq 131I does not affect 131I therapeutic efficacy. Journal of Nuclear Medicine 43(5 Suppl.): 326P, 2002